Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Satta

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2020
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
International Journal of Antimicrobial Agents|April 16, 2019
Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London serviceJames Hatcher, Ceire Costelloe, Richard Cele, et al.
Annals of the American Thoracic Society|December 8, 2016
Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor InhibitorMichael E Murphy, Stephanie Wilmore, Giovanni Satta, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2020
COVID-19 and the potential long-term impact on antimicrobial resistanceTimothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, et al.
Bulletin of the World Health Organization|August 6, 2021
Progress towards antibiotic use targets in eight high-income countriesBryony Simmons, Koya Ariyoshi, Norio Ohmagari, et al.
Jac-Antimicrobial Resistance|March 13, 2024
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patientsSuzanne A M Wenker, Najla Alabdulkarim, John B Readman, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
Jac-Antimicrobial Resistance|June 30, 2021
Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19Timothy M Rawson, Bernard Hernandez, Richard C Wilson, et al.
Journal of Clinical Microbiology|December 16, 2016
Nosocomial Outbreak of Drug-Resistant Streptococcus pneumoniae Serotype 9V in an Adult Respiratory Medicine WardElita Jauneikaite, Zareena Khan-Orakzai, Georgia Kapatai, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2020
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingTimothy M Rawson, Luke S P Moore, Nina Zhu, et al.
BMC Infectious Diseases|June 12, 2021
Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysisSarah Denny, Timothy M Rawson, Peter Hart, et al.
International Journal of Antimicrobial Agents|April 16, 2019
Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London serviceJames Hatcher, Ceire Costelloe, Richard Cele, et al.
Annals of the American Thoracic Society|December 8, 2016
Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor InhibitorMichael E Murphy, Stephanie Wilmore, Giovanni Satta, et al.
The Journal of Antimicrobial Chemotherapy|May 21, 2020
COVID-19 and the potential long-term impact on antimicrobial resistanceTimothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, et al.
Bulletin of the World Health Organization|August 6, 2021
Progress towards antibiotic use targets in eight high-income countriesBryony Simmons, Koya Ariyoshi, Norio Ohmagari, et al.
Jac-Antimicrobial Resistance|March 13, 2024
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patientsSuzanne A M Wenker, Najla Alabdulkarim, John B Readman, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
Jac-Antimicrobial Resistance|June 30, 2021
Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19Timothy M Rawson, Bernard Hernandez, Richard C Wilson, et al.
Journal of Clinical Microbiology|December 16, 2016
Nosocomial Outbreak of Drug-Resistant Streptococcus pneumoniae Serotype 9V in an Adult Respiratory Medicine WardElita Jauneikaite, Zareena Khan-Orakzai, Georgia Kapatai, et al.
Pageof 6